News Image

Data for Lorundrostat in Chronic Kidney Disease and Hypertension Presented at American Society of Nephrology (ASN) Kidney Week 2025

Provided By GlobeNewswire

Last update: Nov 8, 2025

– Late-breaking presentation of Explore-CKD trial at ASN Kidney Week –

– Pivotal Phase 3 Launch-HTN trial featured in the “Best of JAMA and NEJM” session -

Read more at globenewswire.com

MINERALYS THERAPEUTICS INC

NASDAQ:MLYS (11/14/2025, 3:17:07 PM)

40.35

-3.94 (-8.9%)



Find more stocks in the Stock Screener

MLYS Latest News and Analysis

Follow ChartMill for more